ID
25692
Descripción
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876 Study ID: 100789 Clinical Study ID: NKV100789 Study Title: A two-part, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of single intravenous doses of GW679769 when administered alone and in combination with intravenous or oral doses of dexamethasone in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced
Palabras clave
Versiones (2)
- 10/9/17 10/9/17 -
- 10/9/17 10/9/17 -
Subido en
10 de septiembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
Descripción
Eligibility
Alias
- UMLS CUI-1
- C0013893
Descripción
Inclusion Criteria
Alias
- UMLS CUI-1
- C1512693
Descripción
healthy between 18 and 55 years
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C3898900
- UMLS CUI [1,2]
- C0001779
Descripción
childbearing potential
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3831118
Descripción
BMI
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1305855
Descripción
informed consent
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0021430
Descripción
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Descripción
screening finding
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1409616
Descripción
allergy dexamethasone
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0013182
- UMLS CUI [1,2]
- C0011777
Descripción
osteoporosis
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0029456
- UMLS CUI [1,2]
- C1141639
Descripción
concomitant medication
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2347852
Descripción
medical history
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0262926
Descripción
medical history
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0205082
Descripción
cytochrome P450 3A inducer or inhibitors
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3830625
- UMLS CUI [2]
- C3830624
Descripción
herbal or dietary supplements
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0242295
- UMLS CUI [2]
- C1504473
Descripción
blood donor
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0005795
Descripción
investigational drug
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0013230
Descripción
drug screeing
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0743295
Descripción
alcohol consumption
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0001948
Descripción
smoking
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0543414
Descripción
HIV, Hepatitis B or Hepatitis C test positive
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1321876
- UMLS CUI [2]
- C2363788
- UMLS CUI [3]
- C2363789
Similar models
Demography, Eligibility - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876
C0040223 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
C3845569 (UMLS CUI [1,3])
C0001779 (UMLS CUI [1,2])
C0011777 (UMLS CUI [1,2])
C1141639 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
C3830624 (UMLS CUI [2])
C1504473 (UMLS CUI [2])
C2363788 (UMLS CUI [2])
C2363789 (UMLS CUI [3])